Biological, environmental and phenotypic data analyzed in the current study are available in the dbGAP repository (study accession numbers: SAGE phs00921.v1.p1, GALA II phs001180.v1.p1). Psychosocial data analyzed in the current study (experience of discrimination and socioeconomic status) are not publicly available due to the sensitive nature of the data and privacy concerns for study participants. Psychosocial data is currently stored in the UCSF Box repository and is available upon reasonable request at asthma.collaboratory\@ucsf.edu

Introduction {#sec006}
============

Asthma is the most common chronic disease in children \[[@pone.0231782.ref001], [@pone.0231782.ref002]\], with genetic, environmental, and infectious risk factors. \[[@pone.0231782.ref003]--[@pone.0231782.ref005]\] Though the global burden of asthma is increasing, certain racial/ethnic and geographic populations are at especially high risk. Puerto Ricans are among the most severely affected populations in the world. \[[@pone.0231782.ref004]\] Approximately 36.5% of Puerto Ricans report they currently or previously had asthma, compared to 9.4% of African Americans, 7.6% of non-Hispanic whites, and 7.5% of Mexican Americans. \[[@pone.0231782.ref006], [@pone.0231782.ref007]\] These striking differences extend to asthma morbidity and mortality, which are 2.4- and 4-fold higher in Puerto Ricans compared to whites, respectively. \[[@pone.0231782.ref006], [@pone.0231782.ref007]\] Asthma is a complex disease and often presents as a function of genetic, environmental, and socio-cultural risk factors. \[[@pone.0231782.ref008]--[@pone.0231782.ref013]\] Yet asthma, and more specifically asthma disparities, are still not well understood. We propose to examine a single, but significant, facet of asthma that may explain differences in asthma prevalence across minority populations: early-life respiratory illnesses.

Several epidemiological studies have established a strong association between the development of childhood asthma or recurrent wheeze with exposure to severe, early-life respiratory illnesses across populations. \[[@pone.0231782.ref014]--[@pone.0231782.ref024]\] Associations with asthma were strongest for infections caused by respiratory syncytial virus (RSV) \[[@pone.0231782.ref014], [@pone.0231782.ref017], [@pone.0231782.ref020]--[@pone.0231782.ref024]\] and human rhinovirus (HRV), leading to a 2.6 and 9.8 fold probability of asthma, respectively. \[[@pone.0231782.ref018]--[@pone.0231782.ref020]\] Before one year of age, persistent wheezing illness is most commonly caused by RSV, which later changes to HRV in older children. \[[@pone.0231782.ref025]\] Both RSV and HRV are known to cause bronchiolitis, which can be a severe respiratory infection in children and is linked to later asthma development. \[[@pone.0231782.ref022], [@pone.0231782.ref026]\] These viruses have a complex interaction between genetics and environmental exposures in determining risks for asthma and related outcomes. \[[@pone.0231782.ref027], [@pone.0231782.ref028]\] Additionally, Puerto Rico has an RSV season that is year-round whereas the mainland United States only reports a 20-week season (**[Fig 1](#pone.0231782.g001){ref-type="fig"}**). \[[@pone.0231782.ref029], [@pone.0231782.ref030]\]

![Respiratory syncytial virus (RSV) season in Puerto Rico (red) and the mainland United States (blue).\
RSV season begins when 10% or more of RSV tests are positive. Data shown are a simplified representation of the data obtained from McGuinness et al. Pediatr Infect Dis J. 2014. \[[@pone.0231782.ref029]\]](pone.0231782.g001){#pone.0231782.g001}

It is unclear at this time if differential responses to early-life respiratory illnesses contribute to the striking asthma disparities seen across minority populations. It is possible that genetic predisposition, environmental influences, and early-life respiratory illness work together to increase asthma susceptibility in high-risk populations. Our aim was to investigate the association of early-life respiratory illnesses with asthma susceptibility seen in our large and well-phenotyped cohort of minority children. In light of disparate disease prevalence, \[[@pone.0231782.ref006], [@pone.0231782.ref029], [@pone.0231782.ref030]\] we examined this association in each population (Puerto Ricans, African Americans and Mexican Americans), separately and combined. We hypothesize that differences in the prevalence of clinically diagnosed early-life respiratory infections such as upper respiratory infections (URI), pneumonia, bronchitis, and bronchiolitis across populations may be associated with asthma prevalence and further these associations may vary across these three minority population.

Methods {#sec007}
=======

Study population {#sec008}
----------------

The study included participants recruited through two studies: the Genes-Environments and Admixture in Latino Americans (GALA II) study and the Study of African Americans, Asthma, Genes and Environments (SAGE), described in detail elsewhere. \[[@pone.0231782.ref010], [@pone.0231782.ref013], [@pone.0231782.ref031]\] Briefly, GALA II and SAGE are parallel case-control studies of asthma conducted between 2006 to 2014 in Latino (Mexican American and Puerto Rican) and African American children aged 8--21, respectively. SAGE participants were recruited from the San Francisco Bay Area and GALA II participants were recruited from across the continental United States (Chicago, Houston, New York City, and the San Francisco Bay Area) and Puerto Rico. Questionnaires were administered to adult participants and parents of minors. All participants provided written consent to being in the study. Consent was obtained from all adult participants and parent/legal guardians of minor participants. The study protocols for both GALA II and SAGE were approved by the UCSF Human Research Protection Program Institutional Review Board (IRB) and all institutions participating in recruitment obtained the appropriate approvals from their IRBs for recruitment related activity.

Out of a total of 6,023, participants with asthma onset prior to the age of two (n = 1,450) and those individuals without complete illness and covariate data (n = 2,301) were excluded from the study. Those diagnosed with asthma before age two were initially excluded from analysis to better delineate any causal association between early-life respiratory illness before age two and subsequent diagnosis of asthma. The exclusion criteria yielded an analytical sample of 2,824 subjects, including both cases (n = 1,091) and controls (n = 1,733).

Outcomes {#sec009}
--------

The outcome of our study was physician diagnosed asthma diagnosed after the age of two reported by the parent. \[[@pone.0231782.ref031]\] Eligible control subjects had no reported history of asthma, lung disease, or chronic illness, and no reported symptoms of coughing, wheezing, or shortness of breath in the two years before enrollment.

Exposure {#sec010}
--------

The exposure was parental report of physician diagnosed early-life respiratory illnesses within the first two years of life. Early-life respiratory illnesses included URI, pneumonia, bronchitis, and bronchiolitis/RSV, which were analyzed separately. In addition, the report of at least one of the four previous illnesses was used to categorize children with "any respiratory illness" and none otherwise. As this was a retrospective study, we could not rely on pathogen identification as a means to confirm the viral species present during the illness.

Covariates {#sec011}
----------

Consistent with previous studies, \[[@pone.0231782.ref032], [@pone.0231782.ref033]\] we considered factors known to be associated with early-life respiratory illnesses and with asthma. These included sex, underweight at birth (yes/no), maternal smoking during pregnancy (yes/no), whether the subject was breastfed (yes/no), number of older siblings (none, one, two or more), socioeconomic status (SES; low, medium, high; described further in **[S1 Text](#pone.0231782.s001){ref-type="supplementary-material"}**), and recruitment site. However, recruitment site was not included in the African American models because all the participants were recruited from one site only.

Statistical analysis {#sec012}
--------------------

Descriptive statistics were calculated for the overall study population and for each minority population separately. We used logistic regression to quantify the association between physician-diagnosed asthma and self-reported respiratory illnesses in the first two years of life in all three populations (Puerto Ricans, Mexican Americans, and African Americans) combined. In addition to sex, underweight at birth, maternal smoking during pregnancy, breastfeeding, number of older siblings, SES and recruitment site, we adjusted for the underlying substructure of populations in the dataset using global African and European ancestry estimates (described further in **[S2 Text](#pone.0231782.s002){ref-type="supplementary-material"}**) as a proxy. Because race/ethnicity may act as an effect modifier due to the large differences in asthma prevalence, \[[@pone.0231782.ref006], [@pone.0231782.ref007]\] we estimated this association stratified by race/ethnicity. Significance for main effects was determined at *p* \< 0.05. The statistical programming language R version 3.5.1 was used to perform all analyses.

Data availability {#sec013}
-----------------

Biological, environmental and phenotypic data analyzed in the current study are available in the dbGAP repository (study accession numbers: SAGE phs00921.v1.p1, GALA II phs001180.v1.p1). Psychosocial data analyzed in the current study (experience of discrimination and socioeconomic status) are not publicly available due to the sensitive nature of the data and privacy concerns for study participants. Psychosocial data is currently stored in the UCSF Box repository and is available upon reasonable request at <asthma.collaboratory@ucsf.edu>.

Results {#sec014}
=======

Descriptive characteristics of our final study population are presented in **[Table 1](#pone.0231782.t001){ref-type="table"}**. When compared with children without asthma, those with asthma were more likely to be male, to have a mother who smoked during pregnancy, and have lower SES. These distributions were observed in our sample regardless of race/ethnicity with a few exceptions. For instance, while Puerto Rican and Mexican American children without asthma were more likely to be breastfed than their counterparts with asthma, the opposite was true for African Americans. Additionally, we found that Puerto Ricans were 4- to 9-fold more likely to report an RSV infection or bronchiolitis in the first two years of life than Mexican Americans and African Americans, respectively (**[Fig 2](#pone.0231782.g002){ref-type="fig"}**).

![Population-specific proportions of selected respiratory illnesses during the first 2 years of life for our study population.](pone.0231782.g002){#pone.0231782.g002}

10.1371/journal.pone.0231782.t001

###### Descriptive statistics for selected characteristics for GALA II and SAGE participants: 2006--2014.

![](pone.0231782.t001){#pone.0231782.t001g}

                                                              Puerto Rican   Mexican American   African American   Total Population                                                                            
  ----------------------------------------------------------- -------------- ------------------ ------------------ ------------------ ----- ------ ----- ------ ----- ------ ----- ------ ------ ------ ------ ------
  Number of subjects                                          284            100                783                100                375   100    504   100    432   100    446   100    1091   100    1733   100
  Males                                                       150            52.8               361                46.1               212   56.5   210   41.7   218   50.5   187   41.9   580    53.2   758    43.7
  Underweight at birth                                        32             11.3               61                 7.8                24    6.4    35    6.9    36    8.3    45    10.1   92     8.4    141    8.1
  In-utero smoke exposure                                     14             4.9                40                 5.1                14    3.7    9     1.8    78    18.1   54    12.1   106    9.7    103    5.9
  Breastfed                                                   141            49.6               432                55.2               285   76     401   79.6   262   60.6   244   54.7   688    63.1   1077   62.1
  Number of older siblings                                                                                                                                                                                     
   *0*                                                        74             26.1               200                25.5               132   35.2   195   38.7   247   57.2   208   46.6   453    41.5   603    34.8
   *1*                                                        92             32.4               274                35                 138   36.8   176   34.9   101   23.4   132   29.6   331    30.3   582    33.6
   *2 or more*                                                118            41.5               309                39.5               105   28     133   26.4   84    19.4   106   23.8   307    28.1   548    31.6
  Socioeconomic status[\*](#t001fn001){ref-type="table-fn"}                                                                                                                                                    
   *High*                                                     89             31.3               271                34.6               114   30.4   116   23     163   37.7   160   35.9   366    33.5   547    31.6
   *Medium*                                                   51             18                 136                17.4               79    21.1   84    16.7   113   26.2   137   30.7   243    22.3   357    20.6
   *Low*                                                      144            50.7               376                48                 182   48.5   304   60.3   156   36.1   149   33.4   482    44.2   829    47.8
  Recruitment site                                                                                                                                                                                             
   *Chicago*                                                  18             6.3                23                 2.9                137   36.5   180   35.7   \-    \-     \-    \-     155    14.2   203    11.7
   *Houston*                                                  1              0.4                \-                 \-                 96    25.6   91    18.1   \-    \-     \-    \-     97     8.9    91     5.3
   *New York*                                                 27             9.5                34                 4.3                20    5.3    64    12.7   \-    \-     \-    \-     47     4.3    98     5.7
   *San Francisco Bay Area*                                   1              0.4                1                  0.1                122   32.5   169   33.5   432   100    446   100    555    50.9   616    35.5
   *Puerto Rico*                                              237            83.5               725                92.6               \-    \-     \-    \-     \-    \-     \-    \-     237    21.7   725    41.8
  URI                                                         57             20.1               35                 4.5                24    6.4    27    5.4    67    15.5   16    3.6    148    13.6   78     4.5
  Pneumonia                                                   13             4.6                5                  0.6                20    5.3    11    2.2    24    5.6    14    3.1    57     5.2    30     1.7
  Bronchitis                                                  36             12.7               10                 1.3                37    9.9    10    2      16    3.7    6     1.3    89     8.2    26     1.5
  Bronchiolitis/RSV                                           31             10.9               14                 1.8                6     1.6    4     0.8    6     1.4    2     0.4    43     3.9    20     1.2
  Any Listed                                                  89             31.3               54                 6.9                75    20     46    9.1    98    22.7   31    7      262    24     131    7.6

\*Socioeconomic status was derived from a combination of mother's education level, health insurance status, and household income weighted by region, see **[S1 Text](#pone.0231782.s001){ref-type="supplementary-material"}** for more information.

In our total population, we observed that the odds of asthma was 4.31 (95% CI: 3.15--5.96) for URI, 2.66 (95% CI: 1.67--4.30) for pneumonia, 7.04 (95% CI: 4.44--11.60) for bronchitis, 5.82 (95% CI: 3.26--10.80) for bronchiolitis/RSV, and 4.50 (95% CI: 3.52--5.78) if the participant reported having at least one early-life respiratory illness (**[Table 2](#pone.0231782.t002){ref-type="table"} and [Fig 3](#pone.0231782.g003){ref-type="fig"}**). In the population-specific stratified analyses, we also observed that the odds of asthma in Puerto Ricans was 5.25 (95% CI: 3.34--8.37) for URI, 7.23 (95% CI: 2.66--23.0) for pneumonia, 13.0 (95% CI: 6.51--28.20) for bronchitis, 7.27 (95% CI: 3.83--14.50) for bronchiolitis/RSV, and 6.15 (95% CI: 4.21--9.05) if the participant reported having at least one early-life respiratory illness (**[Table 2](#pone.0231782.t002){ref-type="table"} and [Fig 3](#pone.0231782.g003){ref-type="fig"}**). Similarly, and with few exceptions, we observed significant associations between early-life respiratory illness and asthma in Mexican American and in African American children. However, these associations were smaller in magnitude than the ones observed among Puerto Ricans. Specifically, the odds of asthma in Mexican Americans and African Americans, respectively, were 2.17 (95% CI: 1.12--4.24) and 4.77 (95% CI: 2.76--8.71) for URI, 2.05 (95% CI: 0.96--4.61) and 1.90 (95% CI: 0.97--3.86) for pneumonia, 4.78 (95% CI: 2.39--10.40) and 2.70 (95% CI: 1.08--7.71) for bronchitis, 2.01 (95% CI: 0.55--8.15) and 2.90 (95% CI: 0.64--20.40) for bronchiolitis/RSV, and 3.07 (95% CI: 1.99--4.79) and 3.91 (95% CI: 2.55--6.12) if the participant reported having at least one early-life respiratory illness (**[Table 2](#pone.0231782.t002){ref-type="table"} and [Fig 3](#pone.0231782.g003){ref-type="fig"}**).

![Odds ratios plotted on a log scale of the association between early-life respiratory illnesses before the age of two and asthma diagnosis after the age of two according to race/ethnicity and in the total population.](pone.0231782.g003){#pone.0231782.g003}

10.1371/journal.pone.0231782.t002

###### Adjusted[\*](#t002fn001){ref-type="table-fn"} odds ratios and confidence intervals for the association analysis between respiratory illnesses in the first two years of life and physician-diagnosed asthma after the age of two according to race/ethnicity and in the total population in GALA II and SAGE: 2006--2014.

![](pone.0231782.t002){#pone.0231782.t002g}

                      Puerto Rican (n = 1,067)   Mexican American (n = 879)   African American (n = 878)   Total Population (n = 2,824)
  ------------------- -------------------------- ---------------------------- ---------------------------- ------------------------------
  URI                 5.25 (3.34--8.37)          2.17 (1.12--4.24)            4.77 (2.76--8.71)            4.31 (3.15--5.96)
  Pneumonia           7.23 (2.66--23.0)          2.05 (0.96--4.61)            1.90 (0.97--3.86)            2.66 (1.67--4.30)
  Bronchitis          13.0 (6.51--28.20)         4.78 (2.39--10.40)           2.70 (1.08--7.71)            7.04 (4.44--11.60)
  Bronchiolitis/RSV   7.27 (3.83--14.50)         2.01 (0.55--8.15)            2.90 (0.64--20.40)           5.82 (3.26--10.80)
  Any Listed          6.15 (4.21--9.05)          3.07 (1.99--4.79)            3.91 (2.55--6.12)            4.50 (3.52--5.78)

\*Adjusted for sex, underweight at birth, maternal smoking during pregnancy, breastfeeding, number of older siblings, SES, recruitment site and global ancestry. Recruitment site was not included in the African American models as they were recruited from one site only.

To test statistically significant differences in odds ratios between racial/ethnic groups, we compared the beta coefficients using t-tests. \[[@pone.0231782.ref034]\] We found that there were significant differences (*p* \< 0.05) between Puerto Ricans and Mexican Americans for URI and Any Listed, and between Puerto Ricans and African Americans for bronchitis and pneumonia (**[S1 Table](#pone.0231782.s003){ref-type="supplementary-material"}**).

In a separate analysis, we examined these associations including those individuals diagnosed with asthma before the age of two (**[S2 Table](#pone.0231782.s004){ref-type="supplementary-material"}**). Our results showed that all early-life respiratory illnesses were significantly associated (*p* \< 0.05) with asthma diagnosis in our population and regardless of race/ethnicity, with the exception of RSV in Mexican Americans (**[S3 Table](#pone.0231782.s005){ref-type="supplementary-material"}**). It is worth noting that we observed significantly higher odds of asthma in Puerto Ricans than in Mexican Americans for every respiratory infection examined (**[S4 Table](#pone.0231782.s006){ref-type="supplementary-material"}**).

We additionally compared the odds of asthma after an early-life respiratory illness in Puerto Ricans living in Puerto Rico (Islanders) with those living in the mainland United States (Mainlanders); descriptive characteristics for these populations can be found in **[S5 Table](#pone.0231782.s007){ref-type="supplementary-material"}**. We found high asthma odds following early-life respiratory illness in Islanders relative to Mainlanders (**[S6 Table](#pone.0231782.s008){ref-type="supplementary-material"}**) though due to the small number of Mainlanders we were underpowered to detect statistically significant differences between these groups.

Discussion {#sec015}
==========

Overall, we found that early-life respiratory illnesses such as URI, pneumonia, bronchitis, and bronchiolitis/RSV are significantly associated with asthma diagnosis after the age of two regardless of race/ethnicity. However, Puerto Ricans had the strongest associations.

The association between early-life respiratory illnesses and asthma has been well documented. \[[@pone.0231782.ref014]--[@pone.0231782.ref024]\] Yet, little is known about racial/ethnic differences observed for the associations between early-life respiratory illnesses and the development of asthma later on in childhood.

Previous research on the association between early-life respiratory infection and the development of asthma has yielded conflicting results. Having a wheezing illness due to RSV or HRV infection in early life has previously shown to be associated with a 2.6- and 9.8-fold increase, respectively, in asthma odds by age six in a mostly white population. \[[@pone.0231782.ref018]\] Additionally, a recent study found that the severity of the RSV infection was strongly associated with childhood wheezing at age five in a mostly white population. \[[@pone.0231782.ref017]\] However, the vast majority of children infected by respiratory viruses like RSV do not go on to develop respiratory illnesses like recurrent wheezing and asthma. \[[@pone.0231782.ref033]\] Currently, it is unclear why only a minority of children develop asthma after exposure to an early-life respiratory illness. One plausible explanation is that these respiratory illnesses alter the airway in early life, which leads to asthma later on in childhood. In fact, previous studies have shown that in adults with asthma, the airway epithelium is altered in a heterogeneous manner. \[[@pone.0231782.ref035]\] Another possibility is that children who are already genetically or environmentally prone to asthma present with early-life respiratory illness as an early manifestation of asthma. Indeed, previous studies have shown asymptomatic carriage of RSV and rhinovirus in children, \[[@pone.0231782.ref036]--[@pone.0231782.ref038]\] suggesting a spectrum of disease which may be affected by underlying asthma predisposition. \[[@pone.0231782.ref039], [@pone.0231782.ref040]\] Our findings show greater asthma odds associated with early-life respiratory illnesses in all populations studied, but that the odds was stronger in the Puerto Rican population. These findings are consistent with previous studies \[[@pone.0231782.ref040]--[@pone.0231782.ref042]\] showing that early-life respiratory illnesses are significantly associated with the development of asthma and asthma-related outcomes while additionally adding that these associations may vary by region and/or population.

Most children who develop respiratory viral infections in early life experience minor illness, but some develop much more severe illnesses that involve lower respiratory symptoms like wheezing. \[[@pone.0231782.ref015], [@pone.0231782.ref016], [@pone.0231782.ref036]\] These more severe wheezing illnesses at an early stage in life are associated with a high risk for recurrent wheezing and asthma later in childhood, \[[@pone.0231782.ref018], [@pone.0231782.ref019]\] particularly if these wheezing illnesses were caused by RSV or HRV. \[[@pone.0231782.ref014], [@pone.0231782.ref017], [@pone.0231782.ref021]--[@pone.0231782.ref024]\] Puerto Rican children are especially at risk due to the year-round seasonality of RSV infections. \[[@pone.0231782.ref029], [@pone.0231782.ref030]\] In fact, 1,406 cases of bronchiolitis/RSV were reported in children with a mean age of seven months from six Puerto Rican hospitals over a period of nine months. \[[@pone.0231782.ref039]\] Our findings showed that not only is the prevalence of bronchiolitis/RSV infection highest in Puerto Rican children in our study population, but that the odds for asthma among children who have experienced a bronchiolitis/RSV infection in early life was the highest for Puerto Rican Islanders. These observations suggest that the burden of childhood asthma after bronchiolitis/RSV is particularly high Puerto Rican children. While it is known that early-life respiratory infections are associated with asthma, our findings show racial/ethnic disparities for the odds of asthma post-infection in our population, with Puerto Rican children carrying the greater burden of asthma.

In our study of children diagnosed with asthma after two years of age, some confidence intervals were too wide to make definitive conclusions regarding the odds ratios for asthma after infection in different racial/ethnic groups. However, when we included those children diagnosed with asthma before two years of age, we were able to better delineate the association between different respiratory infections and asthma development across racial/ethnic groups. Interestingly Puerto Ricans and Mexican Americans are both considered Hispanic/Latino for pulmonary function testing and other health outcomes. However, these populations had widely divergent prevalence of asthma after early-life respiratory infections. Puerto Ricans consistently had higher odds of asthma after all respiratory infections studied. Whether the observed association between early-life respiratory infection and greater asthma odds is causal of the alarmingly high prevalence of asthma in Puerto Ricans requires further study.

While we are not able to draw definitive conclusions about the greater odds of asthma after respiratory infection in Puerto Rican Islanders versus Mainlanders due to the limited number of mainland US Puerto Rican children studied, we find it interesting that Mainlander Puerto Ricans tended to have a lower odds of asthma after respiratory infections relative to Islanders. This may suggest an environmental effect associated with living in Puerto Rico that affects the prevalence of asthma. Respiratory infections likely represent one of several factors leading to increased asthma in Islander Puerto Ricans relative to Mainlanders, which may include other environmental and socio-cultural factors. Further studies examining this associations in Puerto Ricans living in the island and in the mainland US can help clarify this observation.

Our study may have been limited because the majority (71%) of Puerto Ricans in the GALA study were diagnosed with asthma before the age of two. In contrast, only 35% of Mexican Americans, and 50% of African Americans were diagnosed with asthma before two years old. Our secondary analysis including children diagnosed with asthma before two years of age addressed these differences. Additionally, our exposure measurements were determined retrospectively, which may introduce biases in the data. Specifically, recall bias may affect the accuracy of answers to questions about events in the distant past. However, if bias were to occur, this bias will be non-differential and affect all racial/ethnic groups studied, biasing the results towards the null. This study was underpowered to detect any significant associations of early-life respiratory illnesses on asthma in Puerto Rican Mainlanders versus Puerto Rican Islanders. Thus, we were not able to determine whether the year-round RSV prevalence in Puerto Rico influenced the association between respiratory illnesses and asthma. However, our study suggests that there are clear population-specific differences in asthma susceptibility across a variety of respiratory illnesses using a large cohort of minority children from three distinct racial/ethnic populations. Moreover, our study also benefits from the wide range of clinical, social, and genetic data available on these children.

Conclusion {#sec016}
==========

Early-life respiratory illnesses such as RSV, which is highly prevalent in Puerto Ricans, have previously been associated with asthma. Our findings indicate that early-life respiratory infections are particularly associated with the later development of asthma in our population regardless of race/ethnicity, with Puerto Rican children having the stronger associations.

Supporting information {#sec017}
======================

###### Derivation of socioeconomic status (SES).

(DOCX)

###### 

Click here for additional data file.

###### Derivation of global ancestry estimates.

(DOCX)

###### 

Click here for additional data file.

###### Pairwise comparison of odds ratios for asthma after two years of age following early-life respiratory infection by racial/ethnic group.

*Definition of Abbreviations*: URI = Upper Respiratory Infection.

(DOCX)

###### 

Click here for additional data file.

###### Descriptive statistics for selected characteristics of the study population including those diagnosed with asthma before age two (N = 3,722).

(DOCX)

###### 

Click here for additional data file.

###### Odds ratios and confidence intervals from the population-specific and combined association analysis between respiratory illnesses in the first two years of life and physician-diagnosed asthma according to race/ethnicity and in the total population in GALA II and SAGE: 2006--2014.

*Definition of Abbreviations*: URI = Upper Respiratory Infection.

(DOCX)

###### 

Click here for additional data file.

###### Pairwise comparison of odds ratios for asthma following early-life respiratory infection by racial/ethnic group including those diagnosed with asthma before age two.

(DOCX)

###### 

Click here for additional data file.

###### Descriptive characteristics of Puerto Rican Islanders and Mainlanders.

(DOCX)

###### 

Click here for additional data file.

###### Odds ratios and confidence intervals from the geography-specific analysis between respiratory illnesses in the first two years of life and physician-diagnosed asthma after the age of two in the two Puerto Rican populations: Islanders and Mainlanders.

*Definition of Abbreviations*: URI = Upper Respiratory Infection.

(DOCX)

###### 

Click here for additional data file.

The authors acknowledge the families and patients for their participation and thank the numerous health care providers and community clinics for their support and participation in GALA II / SAGE. In particular, the authors thank study coordinator Sandra Salazar; the recruiters who obtained the data: Duanny Alva, MD, Gaby Ayala-Rodríguez, Lisa Caine, Elizabeth Castellanos, Jaime Colón, Denise DeJesus, Blanca López, Brenda López, MD, Louis Martos, Vivian Medina, Juana Olivo, Mario Peralta, Esther Pomares, MD, Jihan Quraishi, Johanna Rodríguez, Shahdad Saeedi, Dean Soto, Ana Taveras.

RSV

:   respiratory syncytial virus

HRV

:   human rhinovirus

GALA II

:   Genes-Environments and Admixture in Latino Americans

SAGE

:   The Study of African Americans, Asthma, Genes and Environments

URI

:   upper respiratory infection

SES

:   socioeconomic status

10.1371/journal.pone.0231782.r001

Decision Letter 0

Othumpangat

Sreekumar

Academic Editor

© 2019 Sreekumar Othumpangat

2019

Sreekumar Othumpangat

This is an open access article distributed under the terms of the

Creative Commons Attribution License

, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

4 Feb 2020

PONE-D-19-32435

Differential asthma risk following respiratory infection in children from three minority populations

PLOS ONE

Dear Dr. Borrell,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE's publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

We would appreciate receiving your revised manuscript by Mar 20 2020 11:59PM. When you are ready to submit your revision, log on to <https://www.editorialmanager.com/pone/> and select the \'Submissions Needing Revision\' folder to locate your manuscript file.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter.

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: <http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols>

Please include the following items when submitting your revised manuscript:

A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). This letter should be uploaded as separate file and labeled \'Response to Reviewers\'.A marked-up copy of your manuscript that highlights changes made to the original version. This file should be uploaded as separate file and labeled \'Revised Manuscript with Track Changes\'.An unmarked version of your revised paper without tracked changes. This file should be uploaded as separate file and labeled \'Manuscript\'.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

We look forward to receiving your revised manuscript.

Kind regards,

Sreekumar Othumpangat, PhD

Academic Editor

PLOS ONE

Additional Editor Comments (if provided):

In this manuscript authors address whether early life respiratory illness was associated with later life asthma in minority children. There are several concerns that need to be addressed as stated by reviewer 1 and 2.

Authors need to add more information on bronchiolitis of RSV and HRV. It is not clear whether the self-reported asthma or diagnosed by a physician before the age of 2 from the methods presented.

In results the Puerto Ricans were more likely to report RSV infection than the other minorities, does this has anything to do with the genetics or is it fully related to the earlier infection?

Not much information provided with the early life HRV, does the data show a similar effect as RSV?

Discussion may address other factors like environment, genetic variation or life style that could have a role in mainlanders and the islanders.

Line 298 to 302, modify the sentences, to avoid confusion on mainlanders and islanders.

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1\. Please ensure that your manuscript meets PLOS ONE\'s style requirements, including those for file naming. The PLOS ONE style templates can be found at

<http://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf> and <http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf>

2\. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified whether consent was written or verbal/oral. If consent was verbal/oral, please specify: 1) whether the ethics committee approved the verbal/oral consent procedure, 2) why written consent could not be obtained, and 3) how verbal/oral consent was recorded. If your study included minors, please state whether you obtained consent from parents or guardians in these cases.
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**Comments to the Author**

1\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#1: Partly

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

2\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#1: I Don\'t Know

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

3\. Have the authors made all data underlying the findings in their manuscript fully available?

The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing) requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.

Reviewer \#1: Yes

Reviewer \#2: No

\*\*\*\*\*\*\*\*\*\*

4\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

5\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#1: The authors present an analysis looking at the relationship between ethnicity and asthma, using 2006 through 2014 data from two case-control studies (GALA II and SAGE). The authors report that the odds of asthma were higher among Puerto Ricans (from the island of Puerto Rico, not the mainland USA) than the odds observed among Mexican Americans and African Americans.

This study is overall interesting and has scientific merit. There are several issues that the authors need to address and clarifications that are needed, in order to better understand the findings. One big limitation of the study is that it relies upon self-reporting of history of respiratory infections as well as diagnosis of asthma, both of which are subject to recall bias among other biases.

Please refer to attached document for additional recommendations.

Reviewer \#2: In this work, the authors explored the association between early-life respiratory illness and physician-diagnosed asthma at 2 years in three minority populations and found a strong association. Though the findings are not new, it has strengthened existing evidence. The authors need to clearly mention the value of the findings and specific recommendations for the next step.

Specific comments and suggestions:

1\. It would be worth to mention in the background some hypothesis citing previous relevant work why asthma morbidity and mortality has been strikingly higher among Puerto Rican as early-life respiratory infections are one of many drivers that contributes asthma development

2\. It is not clear whether the etiologies of respiratory illnesses (URI, pneumonia, bronchitis) were investigated. Most published works so far reportedly linked early life viral respiratory infections with childhood asthma. If the etiologic data is available it would be good to perform a sub-analysis to look for specific association between viral URI/pneumonia before two years and asthma at two years of age and how this varies by ethnicity

3\. Line 151: It is not clear whether all bronchiolitis episodes had a detectable RSV, although we know that most bronchiolitis is caused by RSV

4\. Line 154: atopic status (this might vary by ethnicity) of enrolled children needed to be addressed as a covariate as this might influence the relationship between respiratory infections and risk of asthma development (<https://www.sciencedirect.com/science/article/abs/pii/S0091674907002382>
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6\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#1: No

Reviewer \#2: Yes: Md. Zakiul Hassan

\[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link \"View Attachments\". If this link does not appear, there are no attachment files to be viewed.\]
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